Lilly Financial Results: Q4/FY 2018

Lilly has announced its financial results, including earnings, for the fourth quarter and full year of 2018.

"Lilly's performance in the fourth quarter of 2018 capped an important year for the company, as we continued to launch new medicines, invest in our pipeline and deliver solid financial results," said Dave Ricks, Lilly's chairman and CEO. "The portfolio of medicines that we have launched over the past five years is providing a strong foundation on which to grow our business, while the pending acquisition of Loxo Oncology is the latest example of our commitment to develop new medicines that will transform the care of many serious illnesses. We are determined to raise the bar even higher in 2019 so that more people around the world can benefit from Lilly medicines."

For more information, visit Lilly's Investor Relations website.